Traina TA - Search Results

1

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.

Gonzalez-Angulo AM, Stemke-Hale K, Palla SL, Carey M, Agarwal R, Meric-Berstam F, Traina TA, Hudis C, Hortobagyi GN, Gerald WL, Mills GB, Hennessy BT. Gonzalez-Angulo AM, et al. Among authors: traina ta. Clin Cancer Res. 2009 Apr 1;15(7):2472-8. doi: 10.1158/1078-0432.CCR-08-1763. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276248

2

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer.

Traina TA, Poggesi I, Robson M, Asnis A, Duncan BA, Heerdt A, Dang C, Lake D, Moasser M, Panageas K, Borgen P, Norton L, Hudis C, Dickler MN. Traina TA, et al. Breast Cancer Res Treat. 2008 Sep;111(2):377-88. doi: 10.1007/s10549-007-9787-1. Epub 2007 Oct 20. Breast Cancer Res Treat. 2008. PMID: 17952589 Clinical Trial.

3

Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.

Traina TA, Theodoulou M, Feigin K, Patil S, Tan KL, Edwards C, Dugan U, Norton L, Hudis C. Traina TA, et al. J Clin Oncol. 2008 Apr 10;26(11):1797-802. doi: 10.1200/JCO.2007.13.8388. J Clin Oncol. 2008. PMID: 18398145 Clinical Trial.

4

Bevacizumab in the treatment of metastatic breast cancer.

Traina TA. Traina TA. Oncology (Williston Park). 2009 Apr 15;23(4):327-32. Oncology (Williston Park). 2009. PMID: 19476261 Free article. Review.

5

PIK3CA mutation associates with improved outcome in breast cancer.

Kalinsky K, Jacks LM, Heguy A, Patil S, Drobnjak M, Bhanot UK, Hedvat CV, Traina TA, Solit D, Gerald W, Moynahan ME. Kalinsky K, et al. Among authors: traina ta. Clin Cancer Res. 2009 Aug 15;15(16):5049-59. doi: 10.1158/1078-0432.CCR-09-0632. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671852

6

Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer.

Traina TA, Rugo HS, Caravelli JF, Patil S, Yeh B, Melisko ME, Park JW, Geneus S, Paulson M, Grothusen J, Seidman AD, Fornier M, Lake D, Dang C, Robson M, Theodoulou M, Flombaum CD, Norton L, Hudis CA, Dickler MN. Traina TA, et al. J Clin Oncol. 2010 Feb 1;28(4):628-33. doi: 10.1200/JCO.2009.21.8784. Epub 2009 Oct 19. J Clin Oncol. 2010. PMID: 19841327 Free PMC article.

7

Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.

Morris PG, Dickler M, McArthur HL, Traina T, Sugarman S, Lin N, Moy B, Come S, Godfrey L, Nulsen B, Chen C, Steingart R, Rugo H, Norton L, Winer E, Hudis CA, Dang CT. Morris PG, et al. J Clin Oncol. 2009 Dec 20;27(36):6117-23. doi: 10.1200/JCO.2008.20.2952. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901120 Free PMC article.

8

Triple-negative breast cancer: role of the androgen receptor.

Gucalp A, Traina TA. Gucalp A, et al. Among authors: traina ta. Cancer J. 2010 Jan-Feb;16(1):62-5. doi: 10.1097/PPO.0b013e3181ce4ae1. Cancer J. 2010. PMID: 20164692 Review.

9

Capecitabine dosing is not yet optimized for breast cancer.

Hudis C, Traina T, Norton L. Hudis C, et al. Ann Oncol. 2010 Nov;21(11):2291; author reply 2291-2. doi: 10.1093/annonc/mdq264. Epub 2010 May 25. Ann Oncol. 2010. PMID: 20501505 No abstract available.

10

Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling.

Traina TA, Dugan U, Higgins B, Kolinsky K, Theodoulou M, Hudis CA, Norton L. Traina TA, et al. Breast Dis. 2010;31(1):7-18. doi: 10.3233/BD-2009-0290. Breast Dis. 2010. PMID: 20519801 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters